Association for Prescription Psychedelics Inc

Nonprofit profile at a glance

EIN
994357431
IRS 990 coverage
2024–2024
Forms available
Form 990 2024
Location
Washington, DC, USA
Phone
2673195207
Rating
52
Verdict
MIXED
Rating confidence
Moderate
Sector
Alliance/Advocacy Organizations

Official website

Reported finances

Revenue
$200,000
Expenses
$140,097
Assets
$60,003
Liabilities
$100

Source: IRS Form 990. Selected filing: tax year 2024. Amounts in USD.

Leadership & pay

1 person listed

Executive titles in this filing

  • Jonathan S Kostas (President/Sec./Treas.)

Highest reported compensation

  • Jonathan S Kostas (President/Sec./Treas.): $20,000 total reported compensation

Source: IRS Form 990. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

To educate, advocate, and accelerate access to safe and effective prescription psychedelic therapies for patients who need them most.

What it reported doing in 2024

Serve as the trusted and recognized industry voice at the national and state levels on prescription psychedelic medicine and its integration into the healthcare system. Demonstrate the importance of government sponsored research, public-private partnerships, patient centricity, and healthcare infrastructure development to support the foundation of this innovative area of medicine. Promote accurate information about prescription psychedelic medicine by educating policymakers, regulators, and other key stakeholders about psychedelics and entactogens/empathogens and the associated medical conditions each compound may be able to treat. Prioritize ethical standards in research, manufacturing, access, and administration of prescription psychedelic medicine to ensure patient safety and well-being. Support patient centered medication treatment guidelines that prioritize the needs and experiences of patients and champion the adoption of fda-approved prescription psychedelics provided by licensed health care providers. Advance responsible legislative and regulatory policies that drive innovation, increase funding for research, and enhance access and coverage for prescription psychedelic medicine. Advocate for the use of prescription psychedelic medication based on rigorous scientific research, clinical trials, and empirical evidence, while supporting ongoing research to expand the field of knowledge. Foster collaboration among industry, academic researchers, healthcare professionals, policy makers and patients to advance understanding and integration of prescription psychedelic medicine into the healthcare system. These activities will be conducted by the association of members, and they will take place in-person at the united states congress and federal government and online. Association for prescription psychedelics, inc. Plans to devote 85 percent of its time to the activities previously outlined and the activity will be funded through member dues. And they will take place in-person at the united states congress and federal government and online. Association for prescription psychedelics, inc. Plans to devote 85 percent of its time to the activities previously outlined and the activity will be funded through member dues.

Operating model

Revenue model
Earned-program. 100% of the money available for current operations came from fees and other program revenue.
Distribution model
Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.

The verdict

MIXED - The filed numbers largely add up. A relatively small share of available resources goes toward mission work and a relatively small share of voting board members are independent.

Rating breakdown

  • Financial Efficiency: 51
  • Transparency & Controls: 90
  • Accountability: 10
  • Sustainability: 54
  • Growth: NotEnoughData

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: 50%; rating input score 50
  • Program expense ratio: 71.4%; rating input score 71
  • Fundraising efficiency: Limited

Transparency & Controls

  • Consistency checks: 100%; rating input score 100; 64th percentile among comparable filings
  • Pay-setting controls: Limited
  • Foreign activity oversight: Limited
  • Grant itemization coverage: Limited
  • Major donor itemization: Limited
  • Related-party transparency: Limited

Accountability

  • Independent voting board: 0%; rating input score 0; 7th percentile among comparable filings
  • Governance controls: 2 of 8 controls in place; rating input score 25
    • Conflict-of-interest policy: Fail
    • Whistleblower policy: Fail
    • Document-retention policy: Fail
    • CEO compensation review process: Fail
    • Other executive compensation review process: NotApplicable
    • Form 990 shared with the board: Pass
    • Board meeting minutes documented: Pass
    • Audit committee oversight: Missing
    • Independent financial-statement audit: Fail

Sustainability

  • Operating margin: 30%; rating input score 82; 82nd percentile among comparable filings
  • Total-asset coverage ratio: 0.43; rating input score 22; 22nd percentile among comparable filings
  • Liabilities to assets ratio: 0; rating input score 55; 55th percentile among comparable filings
  • Officer compensation ratio: 14.3%; rating input score 25; 25th percentile among comparable filings

Growth

  • Program expense growth: Limited
  • Revenue growth: Limited
  • Asset growth: Limited

Details

  • Where the money goes: 50% of revenue deployed · 71.4% of spending went to programs
  • Governance: 0 of 1 board members independent · 2 of 8 filing controls reported
  • Programs: 1 filed program accomplishment · $100K in reported program spending
  • Leadership: top reported pay $20K · 1 people listed
  • Consistency: 16 of 16 current checks pass
  • Schedules: 2 filed schedules
  • Contacts: How to reach this organization
  • Money network: 1 filed money-flow record
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • Review — Financial Efficiency: Mission deployment rate scored 50/100.
  • High — Accountability: Independent voting board scored 0/100.
  • High — Accountability: Governance controls: 5 of 7 not reported.
  • High — Sustainability: Total-asset coverage ratio scored 22/100.
  • High — Sustainability: Officer compensation ratio scored 25/100.
  • Review — Sustainability: Liabilities to assets ratio scored 55/100.